Editas Medicine to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Company Overview - Editas Medicine, Inc. is a leading gene editing company focused on utilizing CRISPR/Cas12a and CRISPR/Cas9 genome editing systems to develop in vivo medicines for serious diseases globally [3]. Upcoming Event - The President and CEO of Editas Medicine, Gilmore O'Neill, will present at the 43rd Annual J.P. Morgan Healthcare Conference on January 15, 2025, at 11:15 a.m. PT / 2:15 p.m. ET in San Francisco, CA [1]. Presentation Access - A live webcast of the presentation will be available on the "Investors" section of the Editas Medicine website, with an archived replay accessible for approximately 30 days post-presentation [2].